Human CD34+/KDR+ cells are generated from circulating CD34+ cells after immobilization on activated platelets

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 2, 2011, Pages 408-415

  De Boer, H C ^a,d   Hovens, M M ^b,e   Van Oeveren Rietdijk, A M ^a,d   Snoep, J D ^b,c   De Koning, E J P ^a   Tamsma, J T ^b   Huisman, M V ^b   Rabelink, A J ^a,d   Van Zonneveld, A J ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Section of Vascular Medicine   (United States)

^c Clinical Epidemiology ^*  (United States)

^d Einthoven Laboratory for Experimental Vascular Medicine   (Netherlands)

^e RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

aspirin; blood flow; diabetes mellitus; platelets; vascular biology

Indexed keywords

ACETYLSALICYLIC ACID; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BONE MARROW; CELL COMPARTMENTALIZATION; CELL SURFACE; CLINICAL ARTICLE; DOUBLE BLIND PROCEDURE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IN VIVO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RANDOMIZED CONTROLLED TRIAL; SHEAR STRESS; THROMBOCYTE ACTIVATION; TREATMENT RESPONSE;

ANTIGENS, CD34; ASPIRIN; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL COMMUNICATION; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; ENDOSOMES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPOTENT STEM CELLS; P-SELECTIN; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, CXCR4; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79551494248     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.216879     Document Type: Article

References (38)

1. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol. 2006;26:257-266.
2. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964-3972. (Pubitemid 29335849)
3. Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci USA. 2005;102:1076-1081.
4. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952-958.
5. Pelosi E, Valtieri M, Coppola S, Botta R, Gabbianelli M, Lulli V, Marziali G, Masella B, Muller R, Sgadari C, Testa U, Bonanno G, Peschle C. Identification of the hemangioblast in postnatal life. Blood. 2002;100:3203-3208.
6. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med. 2004;82: 671-677.
7. de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, Biessen EA, Rabelink TJ, van Zonneveld AJ. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol. 2006;26:1653-1659.
8. Hovens MM, Snoep JD, Groeneveld Y, Frolich M, Tamsma JT, Huisman MV. Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. Diabetes Obes Metab. 2008;10:668-674.
9. Zhang Y, Foudi A, Geay JF, Berthebaud M, Buet D, Jarrier P, Jalil A, Vainchenker W, Louache F. Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells. 2004;22:1015-1029.
10. Wang JF, Park IW, Groopman JE. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phos-phoinositide-3 kinase and protein kinase C. Blood. 2000;95:2505-2513.
11. Ogaeri T, Eto K, Otsu M, Ema H, Nakauchi H. The actin polymerization regulator WAVE2 is required for early bone marrow repopulation by hematopoietic stem cells. Stem Cells. 2009;27:1120-1129.
12. Basu S, Ray NT, Atkinson SJ, Broxmeyer HE. Protein phosphatase 2A plays an important role in stromal cell-derived factor-1/CXC chemokine ligand 12-mediated migration and adhesion of CD34+ cells. J Immunol. 2007;179:3075-3085.
13. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet. 2008;371: 1800-1809.
14. McClung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG, Kappas A. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia. 2005;48: 345-350.
15. Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes Care. 2001;24:1476-1485.
16. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition: a consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
17. Ferroni P, Martini F, Riondino S, La FF, Magnapera A, Ciatti F, Guadagni F. Soluble P-selectin as a marker of in vivo platelet activation. Clin Chim Acta. 2009;399:88-91.
18. Dichiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, Suarez TA, Bailon O, Singla A, Gurbel PA. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. Diabetes. 2007;56:3014-3019.
19. Piatkowski A, Groger A, Pantel M, Bozkurt A, Fuchs PC, Pallua N. The extent of thermal injury affects fractions of mononuclear cells. Burns. 2009;35:256-263.
20. Allan DS, Morgan SC, Birch PE, Yang L, Halpenny MJ, Gunanayagam A, Li Y, Eapen L. Mobilization of circulating vascular progenitors in cancer patients receiving external beam radiation in response to tissue injury. Int J Radiat Oncol Biol Phys. 2009;75:220-224.
21. Rafat N, Hanusch C, Brinkkoetter PT, Schulte J, Brade J, Zijlstra JG, van der Woude FJ, van AK, Yard BA, Beck GC. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med. 2007;35:1677-1684.
22. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke. 2008;39: 69-74.
23. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 2005;105:199-206.
24. Heiss C, Amabile N, Lee AC, Real WM, Schick SF, Lao D, Wong ML, Jahn S, Angeli FS, Minasi P, Springer ML, Hammond SK, Glantz SA, Grossman W, Balmes JR, Yeghiazarians Y. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol. 2008;51:1760-1771.
25. Fox A, Smythe J, Fisher N, Tyler MP, McGrouther DA, Watt SM, Harris AL. Mobilization of endothelial progenitor cells into the circulation in burned patients. Br J Surg. 2008;95:244-251.
26. Kozuka K, Kohriyama T, Nomura E, Ikeda J, Kajikawa H, Nakamura S. Endothelial markers and adhesion molecules in acute ischemic stroke: sequential change and differences in stroke subtype. Atherosclerosis. 2002;161:161-168.
27. Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J. 2006;27:2247-2255.
28. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de KS, Tiengo A, Agostini C, Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol. 2006;26: 2140-2146.
29. Rossig L, Urbich C, Bruhl T, Dernbach E, Heeschen C, Chavakis E, Sasaki K, Aicher D, Diehl F, Seeger F, Potente M, Aicher A, Zanetta L, Dejana E, Zeiher AM, Dimmeler S. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med. 2005;201:1825-1835.
30. Gampel A, Moss L, Jones MC, Brunton V, Norman JC, Mellor H. VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endo-thelial storage compartment. Blood. 2006;108:2624-2631.
31. Sorkin A, von ZM. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol. 2009;10:609-622.
32. Zhang XF, Wang JF, Matczak E, Proper JA, Groopman JE. Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phos-phorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood. 2001;97:3342-3348.
33. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood. 2004;104:3472-3482.
34. Wijelath ES, Rahman S, Murray J, Patel Y, Savidge G, Sobel M. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vasc Surg. 2004;39:655-660.
35. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673-687.
36. Stellos K, Bigalke B, Langer H, Geisler T, Schad A, Kogel A, Pfaff F, Stakos D, Seizer P, Muller I, Htun P, Lindemann S, Gawaz M. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. Eur Heart J. 2009;30:584-593.
37. Petit I, Goichberg P, Spiegel A, Peled A, Brodie C, Seger R, Nagler A, Alon R, Lapidot T. Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. J Clin Invest. 2005;115:168-176.
38. Sekiguchi H, Ii M, Losordo DW. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol. 2009; 219:235-242.